EASL Studio Podcast S5 E1: What is really new in the EASL CPG on ACLF?

EASL Studio Podcast: Highlights of liver cancer research at EASL Congress 2023

EASL Studio Podcast: EASL Congress 2023: Back to the future

EASL Studio Podcast: Practice changing highlights from EASL Congress 2023

EASL Studio Podcast: United we stand: Global societies collaborating to beat liver disease

EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature

EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy

EASL Studio Podcast S4 E23: The conundrum of NASH: The growing global disease burden with low disease awareness

EASL Studio Podcast S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

EASL Studio Podcast S4 E21: Why you should stop smoking if you love your liver

EASL Studio Podcast S4 E20: COST Actions: Opportunities for pan-European collaborations in liver diseases

EASL Studio Podcast S4 Special Edition: Promoting Liver Health: An urgent call for action at WHO

EASL Studio Podcast S4 E19: HDV: The devil becomes treatable

EASL Studio Podcast S4 E18: Liver nurses in Europe: Are there enough and can they do more?

EASL Studio Podcast S4 E17: Albumin in cirrhosis: For all, for some, for none

EASL Studio Podcast S4 E16: Highlights from the EASL Liver Cancer Summit 2023

EASL Studio Podcast S4 E15: Diagnostic and therapeutic challenges in Wilson’s disease

EASL Studio Podcast S4 Special Edition: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillance

EASL Studio Podcast S4 E14: EASL-EF CLIF and EU Grants: Exploring novel mechanism and treatment of chronic liver failure

EASL Studio Podcast S4 E13: JHEP Live: Liver transplantation for alcohol-related hepatitis